| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thymosin | 10 | 2010 | 47 | 2.160 |
Why?
|
| Neovascularization, Pathologic | 20 | 2015 | 2644 | 1.140 |
Why?
|
| Neoplasm Metastasis | 29 | 2015 | 4910 | 1.120 |
Why?
|
| Cell Movement | 35 | 2014 | 5200 | 0.980 |
Why?
|
| Prostatic Neoplasms | 25 | 2022 | 11106 | 0.780 |
Why?
|
| Collagen | 12 | 2014 | 2634 | 0.780 |
Why?
|
| Proteins | 15 | 2019 | 6030 | 0.760 |
Why?
|
| Chemotaxis | 11 | 1999 | 598 | 0.650 |
Why?
|
| Repressor Proteins | 5 | 2020 | 2985 | 0.640 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2016 | 61 | 0.520 |
Why?
|
| Neoplasms | 23 | 2015 | 22131 | 0.520 |
Why?
|
| Cell Adhesion | 17 | 2015 | 3088 | 0.510 |
Why?
|
| Carrier Proteins | 8 | 2022 | 4935 | 0.480 |
Why?
|
| Lymphangiogenesis | 1 | 2015 | 171 | 0.450 |
Why?
|
| Endothelium | 25 | 2012 | 764 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2013 | 8542 | 0.440 |
Why?
|
| Tumor Cells, Cultured | 22 | 2017 | 6126 | 0.420 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2015 | 2048 | 0.420 |
Why?
|
| Paclitaxel | 2 | 2011 | 1730 | 0.420 |
Why?
|
| Neovascularization, Physiologic | 5 | 2012 | 1349 | 0.420 |
Why?
|
| Growth Substances | 14 | 1998 | 768 | 0.420 |
Why?
|
| Platelet-Derived Growth Factor | 12 | 2001 | 618 | 0.400 |
Why?
|
| Cell Line, Tumor | 18 | 2023 | 16967 | 0.400 |
Why?
|
| Lymphatic Metastasis | 4 | 2015 | 2913 | 0.390 |
Why?
|
| Mast Cells | 9 | 1995 | 1392 | 0.390 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2010 | 21 | 0.370 |
Why?
|
| Polyamines | 1 | 2011 | 133 | 0.360 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2533 | 0.360 |
Why?
|
| Genes, APC | 1 | 2011 | 145 | 0.360 |
Why?
|
| Capillaries | 14 | 1995 | 756 | 0.360 |
Why?
|
| Cystatin B | 1 | 2009 | 12 | 0.330 |
Why?
|
| Enzyme Assays | 1 | 2010 | 104 | 0.330 |
Why?
|
| Protein Isoforms | 3 | 2009 | 1697 | 0.310 |
Why?
|
| Animals | 99 | 2020 | 168201 | 0.310 |
Why?
|
| Ornithine Decarboxylase | 2 | 2019 | 63 | 0.310 |
Why?
|
| Molecular Probes | 1 | 2010 | 309 | 0.310 |
Why?
|
| Spermine | 2 | 1999 | 70 | 0.300 |
Why?
|
| Endothelial Cells | 3 | 2015 | 3548 | 0.300 |
Why?
|
| Endothelium, Vascular | 11 | 2015 | 4433 | 0.290 |
Why?
|
| Amino Acid Sequence | 17 | 2019 | 13441 | 0.290 |
Why?
|
| Peptide Hydrolases | 2 | 2010 | 624 | 0.280 |
Why?
|
| Mice, Nude | 8 | 2018 | 3605 | 0.280 |
Why?
|
| Centrioles | 1 | 2007 | 80 | 0.280 |
Why?
|
| Molecular Sequence Data | 17 | 2010 | 17629 | 0.270 |
Why?
|
| Ubiquitin | 3 | 2007 | 839 | 0.270 |
Why?
|
| MicroRNAs | 2 | 2013 | 3805 | 0.270 |
Why?
|
| Lung Neoplasms | 14 | 2015 | 13382 | 0.260 |
Why?
|
| Gold | 1 | 2010 | 481 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2011 | 5304 | 0.260 |
Why?
|
| Centrosome | 1 | 2007 | 209 | 0.260 |
Why?
|
| Cell Division | 16 | 2004 | 4457 | 0.260 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 399 | 0.250 |
Why?
|
| Cell Adhesion Molecules | 5 | 2013 | 1602 | 0.250 |
Why?
|
| Nanoparticles | 4 | 2020 | 1957 | 0.250 |
Why?
|
| Oligopeptides | 8 | 1998 | 1185 | 0.250 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 630 | 0.250 |
Why?
|
| Rats | 23 | 2007 | 23717 | 0.250 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2007 | 1320 | 0.240 |
Why?
|
| Mice | 49 | 2020 | 81368 | 0.240 |
Why?
|
| Signal Transduction | 12 | 2018 | 23416 | 0.230 |
Why?
|
| Adenocarcinoma | 5 | 2010 | 6340 | 0.230 |
Why?
|
| Extracellular Matrix | 9 | 2000 | 1718 | 0.230 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2009 | 782 | 0.230 |
Why?
|
| Apoptosis | 5 | 2020 | 9476 | 0.220 |
Why?
|
| Hematopoietic Cell Growth Factors | 2 | 1995 | 98 | 0.220 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 3705 | 0.220 |
Why?
|
| Fibronectins | 11 | 2000 | 723 | 0.220 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 257 | 0.220 |
Why?
|
| Angiogenesis Inducing Agents | 6 | 1992 | 278 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6925 | 0.210 |
Why?
|
| Neoplasm Proteins | 8 | 2007 | 3607 | 0.210 |
Why?
|
| Proteomics | 5 | 2020 | 3836 | 0.210 |
Why?
|
| Endothelial Growth Factors | 4 | 1999 | 673 | 0.200 |
Why?
|
| Cyclin D1 | 1 | 2004 | 451 | 0.200 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2009 | 2223 | 0.200 |
Why?
|
| RNA, Messenger | 11 | 2020 | 12758 | 0.200 |
Why?
|
| Laminin | 8 | 2014 | 408 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2010 | 9277 | 0.190 |
Why?
|
| Gene Silencing | 3 | 2014 | 1503 | 0.190 |
Why?
|
| Chemotactic Factors | 3 | 1992 | 197 | 0.190 |
Why?
|
| RNA Editing | 1 | 2022 | 151 | 0.190 |
Why?
|
| Humans | 103 | 2023 | 760617 | 0.180 |
Why?
|
| Umbilical Veins | 4 | 2010 | 426 | 0.180 |
Why?
|
| Medical Oncology | 2 | 2014 | 2317 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2020 | 2864 | 0.180 |
Why?
|
| Cells, Cultured | 26 | 2010 | 18937 | 0.180 |
Why?
|
| Allantois | 3 | 2003 | 33 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2000 | 56 | 0.170 |
Why?
|
| Thrombin | 7 | 1979 | 592 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2015 | 5319 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 5 | 2010 | 3792 | 0.170 |
Why?
|
| Neoplasm Transplantation | 4 | 2011 | 2010 | 0.170 |
Why?
|
| Chorion | 3 | 2003 | 114 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2002 | 546 | 0.170 |
Why?
|
| Mass Spectrometry | 5 | 2007 | 2189 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2015 | 737 | 0.170 |
Why?
|
| Lymphokines | 3 | 1999 | 925 | 0.170 |
Why?
|
| Receptors, Cell Surface | 6 | 1993 | 2802 | 0.170 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 1202 | 0.160 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2000 | 187 | 0.160 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2011 | 592 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2002 | 3730 | 0.160 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 3419 | 0.160 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2000 | 242 | 0.160 |
Why?
|
| Base Sequence | 8 | 2011 | 12421 | 0.160 |
Why?
|
| Nucleoside-Diphosphate Kinase | 2 | 1999 | 17 | 0.150 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2000 | 276 | 0.150 |
Why?
|
| Actins | 3 | 2022 | 2050 | 0.150 |
Why?
|
| Disease Progression | 5 | 2013 | 13495 | 0.150 |
Why?
|
| Up-Regulation | 5 | 2011 | 4117 | 0.150 |
Why?
|
| Cattle | 19 | 2007 | 3841 | 0.150 |
Why?
|
| Transfection | 8 | 2018 | 5766 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 1999 | 1492 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3800 | 0.150 |
Why?
|
| Cadherins | 2 | 2013 | 901 | 0.150 |
Why?
|
| beta Catenin | 1 | 2023 | 1039 | 0.150 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 3 | 1995 | 178 | 0.140 |
Why?
|
| Fibroblasts | 8 | 2006 | 4137 | 0.140 |
Why?
|
| Elastin | 5 | 1990 | 298 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2014 | 3426 | 0.140 |
Why?
|
| Genes | 1 | 2000 | 1823 | 0.140 |
Why?
|
| Growth Inhibitors | 2 | 1995 | 375 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 2 | 1999 | 200 | 0.140 |
Why?
|
| Sequence Alignment | 3 | 2009 | 2178 | 0.130 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 420 | 0.130 |
Why?
|
| Carbamates | 1 | 2017 | 191 | 0.130 |
Why?
|
| RNA Interference | 3 | 2010 | 2830 | 0.130 |
Why?
|
| Carcinoma | 4 | 1996 | 2327 | 0.130 |
Why?
|
| 3T3 Cells | 6 | 2001 | 1085 | 0.130 |
Why?
|
| Protein Binding | 8 | 2021 | 9345 | 0.130 |
Why?
|
| Peptides | 8 | 2010 | 4354 | 0.130 |
Why?
|
| Type C Phospholipases | 3 | 2005 | 287 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 4 | 2014 | 3593 | 0.120 |
Why?
|
| Protein Biosynthesis | 3 | 1999 | 2100 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 4020 | 0.120 |
Why?
|
| Plasminogen | 3 | 2001 | 144 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 1989 | 661 | 0.120 |
Why?
|
| Heat-Shock Proteins | 2 | 1997 | 795 | 0.120 |
Why?
|
| Blood Vessels | 6 | 2004 | 1113 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 1994 | 17 | 0.120 |
Why?
|
| Blotting, Western | 6 | 2011 | 5034 | 0.120 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1994 | 74 | 0.120 |
Why?
|
| ras Proteins | 2 | 1999 | 1054 | 0.120 |
Why?
|
| Receptor, Insulin | 2 | 1998 | 836 | 0.110 |
Why?
|
| Glutathione Transferase | 3 | 2010 | 565 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3591 | 0.110 |
Why?
|
| Keratin-18 | 1 | 2013 | 38 | 0.110 |
Why?
|
| Isotope Labeling | 4 | 2010 | 392 | 0.110 |
Why?
|
| Male | 37 | 2022 | 360358 | 0.110 |
Why?
|
| DNA, Complementary | 3 | 2001 | 1989 | 0.110 |
Why?
|
| Membrane Proteins | 7 | 2003 | 7847 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 1650 | 0.110 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 4172 | 0.110 |
Why?
|
| Organ Specificity | 5 | 1996 | 1964 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 753 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 3 | 2010 | 1703 | 0.110 |
Why?
|
| History, 20th Century | 2 | 2014 | 2764 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1698 | 0.110 |
Why?
|
| Epidermal Growth Factor | 4 | 1989 | 699 | 0.110 |
Why?
|
| Neoplasms, Experimental | 7 | 2017 | 1226 | 0.100 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 1037 | 0.100 |
Why?
|
| Vimentin | 1 | 2013 | 255 | 0.100 |
Why?
|
| Chick Embryo | 8 | 2003 | 982 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-sis | 4 | 2000 | 255 | 0.100 |
Why?
|
| Tissue Extracts | 3 | 1995 | 139 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1113 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 1997 | 907 | 0.100 |
Why?
|
| Phospholipase C gamma | 2 | 2005 | 131 | 0.100 |
Why?
|
| Benzimidazoles | 1 | 2017 | 858 | 0.100 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 3074 | 0.100 |
Why?
|
| Antibodies | 2 | 2007 | 2414 | 0.100 |
Why?
|
| DNA Primers | 3 | 2011 | 2817 | 0.100 |
Why?
|
| Cell Line | 15 | 2002 | 15576 | 0.100 |
Why?
|
| Interleukin-3 | 2 | 1992 | 425 | 0.100 |
Why?
|
| Recombinant Proteins | 7 | 2005 | 6520 | 0.100 |
Why?
|
| Catenins | 1 | 2011 | 44 | 0.100 |
Why?
|
| Aqueous Humor | 2 | 1983 | 153 | 0.100 |
Why?
|
| Culture Media | 8 | 1989 | 895 | 0.100 |
Why?
|
| Integrins | 2 | 1993 | 834 | 0.100 |
Why?
|
| Angiostatins | 3 | 2001 | 64 | 0.090 |
Why?
|
| Water | 1 | 2017 | 1409 | 0.090 |
Why?
|
| Transplantation, Heterologous | 3 | 2013 | 2382 | 0.090 |
Why?
|
| Lysophospholipids | 3 | 2000 | 337 | 0.090 |
Why?
|
| Transferrin | 1 | 1992 | 283 | 0.090 |
Why?
|
| Hemangioma | 2 | 1995 | 727 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 458 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 4512 | 0.090 |
Why?
|
| Prostate | 2 | 1996 | 1773 | 0.090 |
Why?
|
| Proton-Translocating ATPases | 1 | 2010 | 112 | 0.090 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2012 | 268 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 3 | 2005 | 2465 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 3 | 2001 | 471 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2012 | 3492 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1998 | 2425 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2015 | 713 | 0.080 |
Why?
|
| Protein Kinases | 1 | 1997 | 1606 | 0.080 |
Why?
|
| Galectin 3 | 1 | 2011 | 240 | 0.080 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 1182 | 0.080 |
Why?
|
| Binding Sites | 4 | 2021 | 6051 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2020 | 10432 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 2012 | 1170 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 2467 | 0.080 |
Why?
|
| Protein Kinase C | 2 | 1993 | 1202 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1242 | 0.080 |
Why?
|
| Polymers | 2 | 2014 | 1614 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3113 | 0.080 |
Why?
|
| Breast Neoplasms | 6 | 2007 | 20988 | 0.080 |
Why?
|
| Cell Communication | 1 | 2015 | 1654 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 550 | 0.080 |
Why?
|
| Trypsin | 2 | 2007 | 495 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 2747 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2010 | 2561 | 0.070 |
Why?
|
| Immune Evasion | 2 | 2021 | 363 | 0.070 |
Why?
|
| Wound Healing | 6 | 2010 | 2802 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5789 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2012 | 1932 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2014 | 1565 | 0.070 |
Why?
|
| Trypsinogen | 1 | 2007 | 84 | 0.070 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 13635 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 399 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 1683 | 0.070 |
Why?
|
| Lipids | 2 | 2018 | 3332 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2021 | 5073 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 1999 | 748 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4269 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1646 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 1692 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2018 | 2456 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 1483 | 0.070 |
Why?
|
| Kinetics | 7 | 2002 | 6370 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 620 | 0.060 |
Why?
|
| Bone Marrow | 3 | 1992 | 2909 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2015 | 3392 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2005 | 226 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1985 | 0.060 |
Why?
|
| Melanoma | 7 | 2004 | 5697 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 2021 | 363 | 0.060 |
Why?
|
| Prognosis | 5 | 2010 | 29600 | 0.060 |
Why?
|
| Mutation | 6 | 2021 | 30016 | 0.060 |
Why?
|
| Cell Membrane | 4 | 2010 | 3680 | 0.060 |
Why?
|
| Lipoproteins, LDL | 2 | 1985 | 642 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2005 | 364 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2000 | 6561 | 0.060 |
Why?
|
| Recurrence | 2 | 2009 | 8426 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 1262 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 1998 | 749 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 669 | 0.060 |
Why?
|
| Blood | 2 | 1977 | 596 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 2 | 2010 | 2894 | 0.060 |
Why?
|
| Talin | 1 | 2004 | 47 | 0.060 |
Why?
|
| Sarcoma, Experimental | 2 | 1983 | 116 | 0.060 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 1995 | 94 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 315 | 0.060 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11116 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1970 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4849 | 0.060 |
Why?
|
| Mitogens | 3 | 1978 | 229 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3206 | 0.050 |
Why?
|
| Macrophage-Activating Factors | 1 | 2003 | 21 | 0.050 |
Why?
|
| Thioredoxins | 1 | 2004 | 202 | 0.050 |
Why?
|
| Actinin | 1 | 2004 | 163 | 0.050 |
Why?
|
| Stem Cell Factor | 2 | 1995 | 195 | 0.050 |
Why?
|
| Endopeptidases | 2 | 1998 | 774 | 0.050 |
Why?
|
| Molecular Imaging | 1 | 2010 | 814 | 0.050 |
Why?
|
| Osteopontin | 1 | 2005 | 301 | 0.050 |
Why?
|
| Furin | 1 | 2003 | 46 | 0.050 |
Why?
|
| Subtilisins | 1 | 2003 | 81 | 0.050 |
Why?
|
| Blood Platelets | 4 | 1982 | 2478 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2021 | 1880 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 1998 | 943 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2005 | 276 | 0.050 |
Why?
|
| Aorta | 5 | 1985 | 2041 | 0.050 |
Why?
|
| Glycoproteins | 3 | 1979 | 2200 | 0.050 |
Why?
|
| Peptide Fragments | 3 | 2001 | 5110 | 0.050 |
Why?
|
| Iliac Artery | 2 | 1987 | 343 | 0.050 |
Why?
|
| Platelet Adhesiveness | 2 | 1982 | 154 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 1229 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1162 | 0.050 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2003 | 131 | 0.050 |
Why?
|
| Molecular Weight | 4 | 1992 | 2185 | 0.050 |
Why?
|
| Tyrosine | 3 | 1998 | 1440 | 0.050 |
Why?
|
| Genes, BRCA2 | 1 | 2005 | 590 | 0.050 |
Why?
|
| Amino Acids | 2 | 2004 | 1717 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 552 | 0.050 |
Why?
|
| Heparin | 3 | 2003 | 1632 | 0.050 |
Why?
|
| Eye Neoplasms | 1 | 1983 | 307 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3599 | 0.050 |
Why?
|
| Cell Extracts | 2 | 1997 | 135 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 2 | 2013 | 5367 | 0.050 |
Why?
|
| Receptors, Very Late Antigen | 2 | 1991 | 74 | 0.050 |
Why?
|
| CHO Cells | 2 | 1994 | 1387 | 0.050 |
Why?
|
| Genes, BRCA1 | 1 | 2005 | 753 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2001 | 361 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 666 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2002 | 1056 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 232 | 0.050 |
Why?
|
| Clone Cells | 3 | 1983 | 1657 | 0.050 |
Why?
|
| Monocytes | 2 | 1987 | 2565 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2003 | 2625 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 2 | 1997 | 34 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2002 | 472 | 0.040 |
Why?
|
| Platelet Factor 4 | 2 | 1996 | 129 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 817 | 0.040 |
Why?
|
| Retinal Vessels | 2 | 1983 | 852 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 22115 | 0.040 |
Why?
|
| Cell Count | 3 | 1996 | 1835 | 0.040 |
Why?
|
| Cricetinae | 2 | 1994 | 2424 | 0.040 |
Why?
|
| Ovary | 1 | 1984 | 959 | 0.040 |
Why?
|
| DNA | 6 | 2000 | 7196 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2010 | 22148 | 0.040 |
Why?
|
| Time | 1 | 2021 | 545 | 0.040 |
Why?
|
| Female | 14 | 2020 | 392148 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2020 | 194 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3777 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2689 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2021 | 725 | 0.040 |
Why?
|
| Insulin | 1 | 1994 | 6593 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 1999 | 316 | 0.040 |
Why?
|
| Luciferases | 1 | 2000 | 712 | 0.040 |
Why?
|
| Factor VIII | 4 | 1983 | 348 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2006 | 11874 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2002 | 534 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2020 | 675 | 0.040 |
Why?
|
| Proteome | 2 | 2010 | 1857 | 0.040 |
Why?
|
| Culture Media, Conditioned | 2 | 2003 | 522 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2000 | 4739 | 0.040 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 2 | 1999 | 21 | 0.040 |
Why?
|
| Teratoma | 2 | 1978 | 404 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2002 | 1084 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 2 | 1998 | 865 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1999 | 12116 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2019 | 319 | 0.040 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1999 | 361 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 968 | 0.040 |
Why?
|
| Survival Rate | 2 | 2010 | 12719 | 0.040 |
Why?
|
| Endometrial Neoplasms | 1 | 2007 | 1365 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 201 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1989 | 221 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 639 | 0.040 |
Why?
|
| Methods | 3 | 1985 | 1065 | 0.040 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1997 | 49 | 0.040 |
Why?
|
| Coliphages | 2 | 1974 | 121 | 0.040 |
Why?
|
| Endostatins | 1 | 1998 | 168 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2010 | 3447 | 0.040 |
Why?
|
| Pituitary Hormones | 1 | 1978 | 182 | 0.040 |
Why?
|
| Prostatectomy | 1 | 2005 | 1824 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 1989 | 2527 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 1520 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2014 | 803 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 460 | 0.030 |
Why?
|
| Mitochondria | 1 | 2010 | 3619 | 0.030 |
Why?
|
| Mouth Diseases | 1 | 1979 | 241 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1993 | 1141 | 0.030 |
Why?
|
| RNA, Antisense | 1 | 1996 | 136 | 0.030 |
Why?
|
| Interferons | 1 | 1980 | 703 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 517 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 489 | 0.030 |
Why?
|
| Phosphorylation | 3 | 1998 | 8311 | 0.030 |
Why?
|
| Epoprostenol | 3 | 1982 | 247 | 0.030 |
Why?
|
| Phosphotransferases | 2 | 1974 | 303 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 1979 | 432 | 0.030 |
Why?
|
| Putrescine | 1 | 1995 | 42 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 1089 | 0.030 |
Why?
|
| Receptors, Immunologic | 2 | 1993 | 1409 | 0.030 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 1995 | 34 | 0.030 |
Why?
|
| ras-GRF1 | 1 | 1995 | 26 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 1130 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 1978 | 2821 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 1996 | 152 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 68 | 0.030 |
Why?
|
| Culture Techniques | 4 | 1982 | 531 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2635 | 0.030 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 1999 | 487 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 6188 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1687 | 0.030 |
Why?
|
| Blastocyst | 1 | 1978 | 432 | 0.030 |
Why?
|
| Microsomes | 1 | 1995 | 251 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 205 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1997 | 638 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 1996 | 176 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1995 | 83 | 0.030 |
Why?
|
| Exons | 1 | 2000 | 2381 | 0.030 |
Why?
|
| Guanidines | 1 | 1995 | 194 | 0.030 |
Why?
|
| Oncogene Protein gp140(v-fms) | 1 | 1994 | 2 | 0.030 |
Why?
|
| Oncogene Proteins v-sis | 1 | 1994 | 2 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 1994 | 5 | 0.030 |
Why?
|
| Epitopes | 1 | 2021 | 2501 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1997 | 397 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2261 | 0.030 |
Why?
|
| Contact Inhibition | 3 | 1978 | 46 | 0.030 |
Why?
|
| Pancreatic Elastase | 2 | 1989 | 127 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2553 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1995 | 813 | 0.030 |
Why?
|
| Muramidase | 1 | 1974 | 167 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2014 | 2048 | 0.030 |
Why?
|
| Hormones | 1 | 1998 | 869 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 58894 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1996 | 1150 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11069 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 1995 | 368 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 1878 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 949 | 0.030 |
Why?
|
| Carcinoma, Lobular | 1 | 1997 | 480 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2014 | 325 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1545 | 0.030 |
Why?
|
| Mesoderm | 2 | 2012 | 674 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2002 | 9529 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 1982 | 1273 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1997 | 754 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 1993 | 321 | 0.030 |
Why?
|
| Podophyllotoxin | 1 | 2012 | 20 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2021 | 6233 | 0.030 |
Why?
|
| Viral Load | 1 | 2021 | 3325 | 0.030 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2012 | 35 | 0.030 |
Why?
|
| Receptors, Cytoadhesin | 1 | 1992 | 8 | 0.030 |
Why?
|
| Antigens | 3 | 1983 | 1441 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2000 | 1662 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 1997 | 791 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 1994 | 557 | 0.020 |
Why?
|
| Cytokines | 2 | 1998 | 7373 | 0.020 |
Why?
|
| Embryoid Bodies | 1 | 2012 | 65 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.020 |
Why?
|
| Research Design | 2 | 2003 | 6174 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1994 | 433 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1995 | 569 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 1996 | 902 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 1994 | 535 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1998 | 2601 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1936 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 2895 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 10754 | 0.020 |
Why?
|
| Biological Factors | 1 | 1992 | 157 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5433 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1999 | 1626 | 0.020 |
Why?
|
| Biological Transport | 1 | 2015 | 2089 | 0.020 |
Why?
|
| United States | 2 | 2021 | 72272 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 1992 | 291 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1997 | 1084 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 578 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2001 | 2446 | 0.020 |
Why?
|
| Tropoelastin | 1 | 1989 | 28 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2000 | 7583 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2012 | 11514 | 0.020 |
Why?
|
| Connective Tissue Cells | 1 | 1989 | 49 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14648 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3150 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 75 | 0.020 |
Why?
|
| Models, Biological | 4 | 2012 | 9461 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 380 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 5780 | 0.020 |
Why?
|
| Mass Screening | 1 | 2005 | 5424 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2722 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 614 | 0.020 |
Why?
|
| Spleen | 2 | 1989 | 2286 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 1990 | 279 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1989 | 218 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2392 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15251 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2007 | 9026 | 0.020 |
Why?
|
| Epithelium | 3 | 1983 | 1603 | 0.020 |
Why?
|
| Staurosporine | 1 | 1989 | 242 | 0.020 |
Why?
|
| Public Health | 1 | 2021 | 2669 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9417 | 0.020 |
Why?
|
| Alkaloids | 1 | 1989 | 192 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 619 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1991 | 358 | 0.020 |
Why?
|
| Venules | 1 | 1988 | 161 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3087 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5780 | 0.020 |
Why?
|
| Cell Separation | 2 | 2001 | 1718 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 1995 | 2894 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1992 | 829 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1988 | 420 | 0.020 |
Why?
|
| Aged | 4 | 2010 | 169042 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4571 | 0.020 |
Why?
|
| Rabbits | 3 | 1988 | 4770 | 0.020 |
Why?
|
| Tuftsin | 1 | 1985 | 4 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1985 | 166 | 0.020 |
Why?
|
| Plant Lectins | 1 | 1985 | 103 | 0.020 |
Why?
|
| Soybean Proteins | 1 | 1985 | 55 | 0.020 |
Why?
|
| Alprostadil | 1 | 1985 | 86 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 789 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 2088 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1608 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1988 | 685 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 6074 | 0.020 |
Why?
|
| Middle Aged | 4 | 2010 | 220584 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 1985 | 112 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2006 | 458 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1992 | 703 | 0.020 |
Why?
|
| Blindness | 2 | 1996 | 584 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2008 | 410 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2006 | 440 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1974 | 4209 | 0.010 |
Why?
|
| Prostaglandins | 2 | 1988 | 398 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 1984 | 81 | 0.010 |
Why?
|
| Adhesiveness | 1 | 1984 | 52 | 0.010 |
Why?
|
| Sarcoma 180 | 1 | 1983 | 6 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9172 | 0.010 |
Why?
|
| Histamine | 1 | 1985 | 499 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1985 | 189 | 0.010 |
Why?
|
| Ovarian Follicle | 1 | 1984 | 244 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 74115 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1987 | 1056 | 0.010 |
Why?
|
| Lung | 3 | 1986 | 9998 | 0.010 |
Why?
|
| Neuraminidase | 1 | 2003 | 195 | 0.010 |
Why?
|
| Arginine | 1 | 2006 | 933 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2010 | 1808 | 0.010 |
Why?
|
| Paxillin | 1 | 2001 | 86 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1985 | 646 | 0.010 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 1984 | 488 | 0.010 |
Why?
|
| Acetylation | 1 | 1984 | 1055 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 1982 | 95 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1998 | 7995 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 574 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1989 | 2409 | 0.010 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2001 | 133 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2903 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1983 | 295 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1983 | 317 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1992 | 3095 | 0.010 |
Why?
|
| Eosinophils | 1 | 1985 | 953 | 0.010 |
Why?
|
| Androgens | 1 | 2008 | 1285 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 20074 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 5812 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2002 | 656 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1980 | 194 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1130 | 0.010 |
Why?
|
| Iris | 1 | 1981 | 232 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2003 | 552 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1079 | 0.010 |
Why?
|
| Education | 1 | 2002 | 534 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2001 | 578 | 0.010 |
Why?
|
| Incidence | 1 | 1998 | 21337 | 0.010 |
Why?
|
| Research | 1 | 2008 | 1977 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1982 | 396 | 0.010 |
Why?
|
| Acantholysis | 1 | 1979 | 11 | 0.010 |
Why?
|
| Retroviridae | 1 | 2001 | 851 | 0.010 |
Why?
|
| Macrophages | 2 | 2003 | 5758 | 0.010 |
Why?
|
| Adult | 4 | 2010 | 220969 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18221 | 0.010 |
Why?
|
| Membrane Fluidity | 1 | 1978 | 68 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 1982 | 676 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 326 | 0.010 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 1979 | 61 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1981 | 573 | 0.010 |
Why?
|
| Lichen Planus | 1 | 1979 | 70 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1998 | 120 | 0.010 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 1979 | 85 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1977 | 80 | 0.010 |
Why?
|
| Retinal Detachment | 1 | 1982 | 428 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1983 | 653 | 0.010 |
Why?
|
| Pemphigus | 1 | 1979 | 107 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1998 | 186 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1985 | 1901 | 0.010 |
Why?
|
| Birds | 1 | 1978 | 168 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1983 | 1151 | 0.010 |
Why?
|
| Endoderm | 1 | 1978 | 160 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1977 | 76 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 1997 | 162 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 444 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1979 | 552 | 0.010 |
Why?
|
| Specimen Handling | 1 | 1981 | 701 | 0.010 |
Why?
|
| Diploidy | 1 | 1976 | 132 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2003 | 1550 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2137 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1979 | 419 | 0.010 |
Why?
|
| Thermolysin | 1 | 1976 | 14 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1978 | 281 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1992 | 3752 | 0.010 |
Why?
|
| Bromelains | 1 | 1976 | 8 | 0.010 |
Why?
|
| Cornea | 2 | 1988 | 1332 | 0.010 |
Why?
|
| Papain | 1 | 1976 | 65 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1988 | 3309 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1336 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1997 | 332 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 1999 | 558 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1999 | 664 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1978 | 618 | 0.010 |
Why?
|
| Mitosis | 2 | 1980 | 1187 | 0.010 |
Why?
|
| RNA, Bacterial | 2 | 1974 | 393 | 0.010 |
Why?
|
| Species Specificity | 1 | 1979 | 2411 | 0.010 |
Why?
|
| Pimelic Acids | 1 | 1974 | 2 | 0.010 |
Why?
|
| Deoxyribonucleotides | 1 | 1974 | 43 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1976 | 378 | 0.010 |
Why?
|
| Thymine Nucleotides | 1 | 1974 | 57 | 0.010 |
Why?
|
| Swine | 1 | 1984 | 5907 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 2639 | 0.010 |
Why?
|
| Flavonoids | 1 | 1997 | 445 | 0.010 |
Why?
|
| Breast Diseases | 1 | 1997 | 443 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1974 | 299 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1980 | 1526 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1984 | 1405 | 0.010 |
Why?
|
| Cartilage | 1 | 1978 | 806 | 0.010 |
Why?
|
| Tritium | 1 | 1974 | 706 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1976 | 564 | 0.010 |
Why?
|
| Serotonin | 1 | 1978 | 1041 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1977 | 1755 | 0.010 |
Why?
|
| Embryonic Development | 1 | 1978 | 721 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 561 | 0.010 |
Why?
|
| Diabetes Mellitus | 2 | 1999 | 5835 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1974 | 357 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1978 | 1670 | 0.010 |
Why?
|
| Inflammation | 1 | 1992 | 10760 | 0.010 |
Why?
|
| Leukocytes | 1 | 1980 | 2023 | 0.010 |
Why?
|
| Software | 1 | 2006 | 4431 | 0.010 |
Why?
|
| Liver | 2 | 1985 | 7512 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1978 | 1096 | 0.010 |
Why?
|
| Ethanol | 1 | 1997 | 1320 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 1990 | 25 | 0.010 |
Why?
|
| Receptors, Laminin | 1 | 1990 | 26 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 1990 | 37 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1990 | 168 | 0.010 |
Why?
|
| Temperature | 1 | 1977 | 2223 | 0.010 |
Why?
|
| Viral Proteins | 2 | 1974 | 1799 | 0.010 |
Why?
|
| Gestational Age | 1 | 1978 | 3577 | 0.010 |
Why?
|
| Contrast Media | 1 | 2002 | 5305 | 0.000 |
Why?
|
| Breast | 1 | 1997 | 1963 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8166 | 0.000 |
Why?
|
| Kidney | 1 | 1983 | 7045 | 0.000 |
Why?
|
| Glucose | 1 | 1999 | 4345 | 0.000 |
Why?
|
| Indomethacin | 1 | 1988 | 323 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 174 | 0.000 |
Why?
|
| Antiviral Agents | 1 | 1980 | 3039 | 0.000 |
Why?
|
| Time Factors | 2 | 2001 | 39913 | 0.000 |
Why?
|
| Heparitin Sulfate | 1 | 1988 | 223 | 0.000 |
Why?
|
| Virus Replication | 1 | 1974 | 2427 | 0.000 |
Why?
|
| Yolk Sac | 1 | 1985 | 79 | 0.000 |
Why?
|
| Skin | 1 | 1979 | 4473 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1974 | 2838 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1985 | 696 | 0.000 |
Why?
|
| Ligands | 1 | 1990 | 3268 | 0.000 |
Why?
|
| Bacterial Proteins | 2 | 1974 | 3842 | 0.000 |
Why?
|
| Lectins | 1 | 1985 | 489 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1983 | 306 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1990 | 3965 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1983 | 645 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1980 | 294 | 0.000 |
Why?
|
| Indoles | 1 | 1985 | 1830 | 0.000 |
Why?
|
| Platelet Aggregation | 1 | 1980 | 771 | 0.000 |
Why?
|
| Muscle, Smooth | 1 | 1980 | 927 | 0.000 |
Why?
|
| Pregnancy | 1 | 1978 | 29868 | 0.000 |
Why?
|
| Coronary Disease | 1 | 1988 | 5912 | 0.000 |
Why?
|
| Adolescent | 2 | 1997 | 88234 | 0.000 |
Why?
|
| Chloramphenicol | 1 | 1972 | 67 | 0.000 |
Why?
|
| Genetics, Microbial | 1 | 1972 | 53 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1988 | 4308 | 0.000 |
Why?
|
| Chromatin | 1 | 1983 | 2955 | 0.000 |
Why?
|
| Rifampin | 1 | 1972 | 339 | 0.000 |
Why?
|
| Potassium | 1 | 1972 | 1311 | 0.000 |
Why?
|
| Infant | 1 | 1982 | 36152 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1982 | 42188 | 0.000 |
Why?
|
| Child | 1 | 1982 | 80079 | 0.000 |
Why?
|